Shimadzu

Shimadzu Medical Systems USA installs first TRINIAS SCORE OPERA Cardiac Catheterization Lab in the US

Retrieved on: 
Friday, October 13, 2023

LONG BEACH, Calif., Oct. 13, 2023 /PRNewswire/ -- Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, is proud to announce the first U.S. installation of a Trinias SCORE Opera C12 (ceiling-mounted cutting edge angiography system) at Beaufort Memorial Hospital (Beaufort, SC).

Key Points: 
  • LONG BEACH, Calif., Oct. 13, 2023 /PRNewswire/ -- Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, is proud to announce the first U.S. installation of a Trinias SCORE Opera C12 (ceiling-mounted cutting edge angiography system) at Beaufort Memorial Hospital (Beaufort, SC).
  • Shimadzu Medical Systems USA, is proud to announce the first U.S. installation of a Trinias SCORE Opera C12!
  • Beaufort Memorial Hospital marked the 20th anniversary of the Cochrane Heart Center with the opening of its newly renovated cardiac catheterization lab outfitted with the most advanced technology in the nation.
  • These patients require an urgent, minimally invasive stenting procedure called percutaneous coronary intervention (PCI) that is performed in the cath lab.

Global Preparative and Process Chromatography Market to Reach $19.04 Billion by 2030 with a 9.08% CAGR: Key Factors Driving Robust Growth Unveiled - ResearchAndMarkets.com

Retrieved on: 
Wednesday, September 20, 2023

The "Preparative And Process Chromatography Market Size, Share & Trends Analysis Report By Product (Process Chromatography, Preparative Chromatography), By End-use (Food, Nutraceutical), By Type, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Preparative And Process Chromatography Market Size, Share & Trends Analysis Report By Product (Process Chromatography, Preparative Chromatography), By End-use (Food, Nutraceutical), By Type, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.
  • The global preparative and process chromatography market is anticipated to achieve a staggering USD 19.04 billion by the year 2030, boasting a remarkable Compound Annual Growth Rate (CAGR) of 9.08% over the forecast period.
  • A pivotal factor in the global market's growth is the burgeoning investments from both government and private sectors in separation and process chromatography.
  • For instance, Shimadzu Corporation unveiled their cutting-edge "Advanced i-Series" High-Performance Liquid Chromatography (HPLC) in November 2020, a flagship liquid chromatography machine that can be operated remotely.

Cybersecurity for Diagnostic Imaging Equipment to Increase in Importance

Retrieved on: 
Thursday, September 21, 2023

ARLINGTON, Va., Sept. 21, 2023 /PRNewswire-PRWeb/ -- Service and maintenance have long been important aspects of managing diagnostic imaging equipment, and with an increase in equipment connectivity and hospital networking, cybersecurity is becoming a growing concern.

Key Points: 
  • According to an IMV survey, 78% expect the importance of cybersecurity to diagnostic imaging equipment to increase in importance over the next few years.
  • ARLINGTON, Va., Sept. 21, 2023 /PRNewswire-PRWeb/ -- Service and maintenance have long been important aspects of managing diagnostic imaging equipment, and with an increase in equipment connectivity and hospital networking, cybersecurity is becoming a growing concern.
  • Of the survey respondents who participated in our IMV 2023 Diagnostic Imaging Equipment Service Outlook Report , 78% indicated they expect the importance of cybersecurity to increase, 19% stated they expected it to stay the same, and 3% said they expected it to decrease in importance in 2024 and beyond.
  • IMV's 2023 Diagnostic Imaging Equipment Service Outlook Report explores market trends related to service contracts for diagnostic imaging equipment in U.S. hospitals.

Label-free Detection Market worth $863 million | MarketsandMarkets

Retrieved on: 
Thursday, July 20, 2023

Key Points: 
  • Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=32435593
    Real-time analysis: Label-free detection techniques provide instant and continuous monitoring of molecular interactions, allowing researchers to observe dynamic processes in real-time.
  • Sensitivity and specificity: Label-free detection systems offer high sensitivity and specificity, enabling the detection of low concentrations of analytes in complex biological or environmental samples.
  • Wide range of applications: Label-free detection technology finds applications in various fields, including life sciences (biological interactions, protein-protein interactions, etc.
  • ), pharmaceuticals (drug discovery and development), food safety (detection of contaminants), and environmental monitoring (water quality analysis, pollutant detection), among others.

Label-free Detection Market worth $863 million | MarketsandMarkets

Retrieved on: 
Thursday, July 20, 2023

Key Points: 
  • Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=32435593
    Real-time analysis: Label-free detection techniques provide instant and continuous monitoring of molecular interactions, allowing researchers to observe dynamic processes in real-time.
  • Sensitivity and specificity: Label-free detection systems offer high sensitivity and specificity, enabling the detection of low concentrations of analytes in complex biological or environmental samples.
  • Wide range of applications: Label-free detection technology finds applications in various fields, including life sciences (biological interactions, protein-protein interactions, etc.
  • ), pharmaceuticals (drug discovery and development), food safety (detection of contaminants), and environmental monitoring (water quality analysis, pollutant detection), among others.

Shimadzu Medical Systems USA announces the release of V series Glass-Free Flat Panel Detectors for general radiography systems.

Retrieved on: 
Thursday, July 6, 2023

LONG BEACH, Calif., July 6, 2023 /PRNewswire/ -- Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, is proud to announce the release of new V series Glass-Free Flat Panel Detectors (FPD) which are now compatible with our general radiography systems.

Key Points: 
  • LONG BEACH, Calif., July 6, 2023 /PRNewswire/ -- Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, is proud to announce the release of new V series Glass-Free Flat Panel Detectors (FPD) which are now compatible with our general radiography systems.
  • With the new Glass-Free FPDs, we can offer a comprehensive V series lineup to support the demands of versatile solutions
    With the new Glass-Free FPDs, we can truly offer a comprehensive V series lineup to support the demands of versatile solutions.
  • Also, the lightweight design helps reduce the physical burden on radiology technologists while increasing robustness to stand accidental drops.
  • The V series Glass-Free FPDs come in three sizes, 17"x17", 14"x17" and 10"x12", and are available for our RADspeed Pro style edition V series and MobileDaRt Evolution MX8 V type.

Shimadzu Medical Systems USA announces the release of Dynamic Digital Radiography function for MobileDaRt Evolution MX8 k type

Retrieved on: 
Wednesday, July 5, 2023

LONG BEACH, Calif., July 5, 2023 /PRNewswire/ -- Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, is proud to announce the release of Dynamic Digital Radiography (DDR) function for MobileDaRt Evolution MX8 k type.

Key Points: 
  • LONG BEACH, Calif., July 5, 2023 /PRNewswire/ -- Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, is proud to announce the release of Dynamic Digital Radiography (DDR) function for MobileDaRt Evolution MX8 k type.
  • This product will be showcased at the AHRA (American Healthcare Radiology Administrators) Annual Meeting and Exposition, held in Indianapolis, IN from July 10 to 12.
  • MobileDaRt Evolution MX8 Version k type can now support capabilities with the DDR option.
  • DDR is an advanced X-ray technology that makes it possible to provide a series of individual digital images from a sequence of pulsed X-rays creating dynamic imaging studies.

New Preliminary Findings on Potential Response Indicator of Rakuten Medical's Alluminox Treatment from Phase 2 Window of Opportunity Study at SNMMI 2023

Retrieved on: 
Friday, June 30, 2023

SAN DIEGO, June 30, 2023 /PRNewswire/ -- Rakuten Medical, Inc., a global biotechnology company developing and commercializing precision, cell targeting therapies based on its proprietary Alluminox™ platform, today announced that new interim evaluation data from the ASP-1929-103 study has been presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2023 Annual Meeting held from June 24 to 27.  ASP-1929-103 is a Phase 2, open-label, single-arm, window of opportunity study* of Alluminox treatment (photoimmunotherapy: PIT) using an antibody-dye conjugate ASP-1929 with fluorescence imaging (ClinicalTrials.gov Identifier: NCT05182866) in patients with operable primary or recurrent head and neck squamous cell carcinoma (HNSCC) or cutaneous squamous cell carcinoma (cuSCC).  

Key Points: 
  • ASP-1929-103 is the very first clinical trial of Alluminox treatment in operable cancer.
  • As part of this trial, early time point (1 day) 18F-FDG PET/CT imaging was investigated as a potential response indicator of Alluminox treatment.
  • The preliminary, descriptive imaging analysis based on interim evaluation of 6 patients in ASP-1929-103 study presented during the meeting showed that 18F-FDG PET/CT imaging demonstrates a therapeutic response 1 day after Alluminox treatment using ASP-1929.
  • ASP-1929-103 is a Phase 2, open-label, single-arm, window of opportunity study* of Alluminox treatment (PIT) using an anti-EGFR antibody-dye conjugate, ASP-1929 with fluorescence imaging in patients with operable primary or recurrent HNSCC or cuSCC.

Mass Spectrometry Market worth $6.8 billion | MarketsandMarkets

Retrieved on: 
Monday, June 26, 2023

In summary, the mass spectrometry market offers high sensitivity, structural characterization, versatility, quantitative analysis, selectivity, rapid analysis, and advancements in data analysis.

Key Points: 
  • In summary, the mass spectrometry market offers high sensitivity, structural characterization, versatility, quantitative analysis, selectivity, rapid analysis, and advancements in data analysis.
  • Mass Spectrometry Market – Report Highlights:
    In this report, mass spectrometry are considered, along with tables and accessories, used for healthcare applications pharmaceutical industries.
  • The study consists of the average selling price (ASP) analysis for different products in the mass spectrometry market.
  • These companies have emerged as key market players in recent years due to their products and various strategic investments undertaken in the mass spectrometry market space.

Mass Spectrometry Market worth $6.8 billion | MarketsandMarkets

Retrieved on: 
Monday, June 26, 2023

In summary, the mass spectrometry market offers high sensitivity, structural characterization, versatility, quantitative analysis, selectivity, rapid analysis, and advancements in data analysis.

Key Points: 
  • In summary, the mass spectrometry market offers high sensitivity, structural characterization, versatility, quantitative analysis, selectivity, rapid analysis, and advancements in data analysis.
  • Mass Spectrometry Market – Report Highlights:
    In this report, mass spectrometry are considered, along with tables and accessories, used for healthcare applications pharmaceutical industries.
  • The study consists of the average selling price (ASP) analysis for different products in the mass spectrometry market.
  • These companies have emerged as key market players in recent years due to their products and various strategic investments undertaken in the mass spectrometry market space.